Speakers include: Dr Scott Glaser, Director Molecular Engineering, Biogen Idec Dr Tristan Vaughan, Senior Director Lead Generation, MedImmune Dr Juan Carlos Almagro, Head Antibody Design Group, Centocor Dr Stefan Bassarab, Director Pharmaceutical Development, Boehringer Ingelheim Professor Jan van de Winkel, Chief Scientific Officer, Genmab Jonathan Klein-Evans, Vice President Intellectual Property, MedImmune Dr Mark Sliwkowski, Director Translational Oncology, Genentech Dr Eric Furfine, Senior Vice President Research and Preclinical Development, Adnexus
|
